Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stark Project: Statins and Risk of Post-Endoscopic Retrograde Cholangiopancreatography Acute Pancreatitits.

NCT06367322 is registered in ClinicalTrials.gov with Hospital General Universitario de Alicante as lead sponsor.

NCT NCT06367322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06367322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stark Project: Statins and Risk of Post-Endoscopic Retrograde Cholangiopancreatography Acute Pancreatitits.
Lead sponsor
Hospital General Universitario de Alicante
Phase
Observational
Overall status
Completed
Start date
January 10, 2017
Completion date
September 30, 2018
Enrollment
1,016 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis